Penn Capital Management Company, LLC Exelixis, Inc. Transaction History

Penn Capital Management Company, LLC

$919 Million
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $66,149 - $87,845	3,793 Added 4.4%	90,050 $1.88 Million
Q1 2022 May 17, 2022	BUY	$17.03 - $22.67 $228,440 - $304,095	13,414 Added 18.41%	86,257 $1.96 Million
Q4 2021 Feb 17, 2022	SELL	$15.84 - $21.88 $291,772 - $403,029	-18,420 Reduced 20.18%	72,843 $1.38 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $31,328 - $40,631	-1,922 Reduced 2.06%	91,263 $1.93 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $4.69 Million - $6.68 Million	-261,271 Reduced 73.71%	93,185 $1.7 Million
Q1 2021 May 13, 2021	BUY	$20.53 - $25.22 $165,800 - $203,676	8,076 Added 2.33%	354,456 $8.01 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $1.39 Million - $1.88 Million	75,668 Added 27.95%	346,380 $6.95 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $652,241 - $850,091	-31,555 Reduced 10.44%	270,712 $6.69 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $3.47 Million - $5.78 Million	-210,953 Reduced 41.1%	302,267 $7.27 Million
Q1 2020 May 13, 2020	BUY	$14.46 - $21.8 $818,913 - $1.23 Million	56,633 Added 12.4%	513,220 $8.93 Million
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $930,225 - $1.16 Million	-61,401 Reduced 11.85%	456,587 $8.05 Million
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $205,830 - $263,691	-11,642 Reduced 2.2%	517,988 $9.16 Million
Q2 2019 Aug 08, 2019	SELL	$18.93 - $24.75 $81,455 - $106,499	-4,303 Reduced 0.81%	529,630 $11.3 Million
Q1 2019 May 07, 2019	BUY	$19.6 - $24.76 $2.27 Million - $2.87 Million	115,976 Added 27.75%	533,933 $12.7 Million
Q1 2019 May 06, 2019	SELL	$19.6 - $24.76 $2.7 Million - $3.41 Million	-137,689 Reduced 24.78%	417,957 $12.8 Million
Q4 2018 Feb 19, 2019	BUY	$13.65 - $21.8 $7.13 Million - $11.4 Million	522,002 Added 1551.55%	555,646 $13.5 Million
Q3 2018 Nov 19, 2018	SELL	$15.87 - $22.4 $29,629 - $41,820	-1,867 Reduced 5.26%	33,644 $1.55 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $1.04 Million - $1.47 Million	-65,425 Reduced 64.82%	35,511 $1.63 Million
Q2 2018 Jul 25, 2018	BUY	$18.56 - $22.45 $589,001 - $712,450	31,735 Added 45.86%	100,936 $2.26 Million
Q1 2018 May 11, 2018	BUY	$22.15 - $31.89 $1.53 Million - $2.21 Million	69,201 New	69,201 $1.59 Million

Others Institutions Holding EXEL

# of Institutions

566

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

Black Rock Inc. New York, NY

33.5M
Shares

$1.24 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.4M
Shares

$1.09 Billion
0.02% of portfolio
Farallon Capital Management LLC San Francisco, CA

23.4M
Shares

$866 Million
4.16% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.3M
Shares

$565 Million
0.8% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$421 Million
0.02% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.

Account